Mozhu Ding

Mozhu Ding

Auto-generated profile, based on publicly available information

Mozhu Ding

Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2018 in Neurology
Verified
Journal Article
Open access
PDF file
MDMozhu Ding
Mozhu Ding
LFLaura Fratiglioni
Laura Fratiglioni
KJKristina Johnell
Kristina Johnell
GSGiola Santoni
Giola Santoni
JFJohan Fastbom
Johan Fastbom
CQChengxuan Qiu
Chengxuan Qiu
Objective To examine the association of atrial fibrillation (AF) with cognitive decline and dementia in old age, and to explore the cognitive benefit of antithrombotic treatment in patients with AF. Methods This population-based cohort study included 2,685 dementia-free participants from the Swedish National Study on Aging and Care in Kungsholmen, who were regularly examined from 2001–2004 to 2010–2013. AF was ascertained from clinical examination, ECG, and patient registry. Global cognitive function was assessed using the Mini-Mental State Examination. We followed the DSM-IV criteria for the diagnosis of dementia, the NINDS-AIREN (National Institute of Neurological Disorders and Stroke and Association Internationale pour la Recherché et l9Enseignement en Neurosciences) criteria for vascular dementia, and the NINCDS-ADRDA (National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer9s Disease and Related Disorders Association) criteria for Alzheimer disease. Data were analyzed using multiple linear mixed-effects and Cox regression models. Results We identified 243 participants (9.1%) with AF at baseline. During the 9-year follow-up period, 279 participants (11.4%) developed AF and 399 (14.9%) developed dementia. As a time-varying variable, AF was significantly associated with a faster annual Mini-Mental State Examination decline (β coefficient = −0.24, 95% confidence interval [CI]: −0.31 to −0.16) and an increased hazard ratio (HR) of all-cause dementia (HR = 1.40, 95% CI: 1.11–1.77) and vascular and mixed dementia (HR = 1.88, 95% CI: 1.09–3.23), but not Alzheimer disease (HR = 1.33, 95% CI: 0.92–1.94). Among people with either prevalent or incident AF, use of anticoagulant drugs, but not antiplatelet treatment, was associated with a 60% decreased risk of dementia (HR = 0.40, 95% CI: 0.18–0.92). Conclusion AF is associated with a faster global cognitive decline and an increased risk of dementia in older people. Use of anticoagulant drugs may reduce dementia risk in patients with AF.

21 February 2023 in The Lancet Regional Health - Europe
Verified
Journal Article
Open access
MDMozhu Ding
Mozhu Ding
MEMarcus Ebeling
Marcus Ebeling
LZLouise Ziegler
Louise Ziegler
AWAlexandra Wennberg
Alexandra Wennberg
KMKarin Modig
Karin Modig
Great efforts have been made to improve stroke prevention in atrial fibrillation (AF) patients. Meanwhile, incidence of AF is increasing, which may affect the share of AF-related stroke on all strokes. We aimed to examine the temporal trends in the incidence of AF-related ischemic stroke between 2001 and 2020, if it varied by use of novel oral anticoagulant drugs (NOAC), and if the relative risk of ischemic stroke associated with AF changed over time. Data from the total Swedish population aged ≥70 years during the period 2001–2020 were used. Annual incidence rate (IR) was calculated for overall and AF-related ischemic stroke which was defined as first-ever ischemic stroke with AF diagnosed up to 5 years before, on the same day, or within 2 months after the stroke event. Cox regression models were performed to examine if the hazard ratio (HR) between AF and stroke changed over time. While IR of ischemic strokes declined during 2001–2020, IR of AF-related ischemic stroke remained stable between 2001 and 2010 but showed a consistent decline between 2010 and 2020. The HR of ischemic stroke within 3 years from an AF diagnosis came down from 2.39 (95% confidence interval: 2.31–2.48) to 1.54 (1.48–1.61) over the study period, which was largely explained by a substantial increase in the use of NOAC among AF patients after 2012. Yet, by the end of 2020, 24% of all ischemic strokes had a preceding or concurrent AF diagnosis, which is slightly higher than in 2001. Even though both the absolute and relative risk of AF-related ischemic stroke declined over the past 20 years, every fourth ischemic stroke in 2020 still had a preceding or concurrent AF diagnosis. This represents a great potential for future gains in stroke prevention among AF patients. 10.13039/501100004359 Swedish Research Council and 10.13039/100010771 Loo and Hans Osterman Foundation for Medical Research .

9 April 2020 in Alzheimer's & Dementia
Verified
Journal Article
Open access
PDF file
MDMozhu Ding
Mozhu Ding
CQChengxuan Qiu
Chengxuan Qiu
DRDebora Rizzuto
Debora Rizzuto
GGGiulia Grande
Giulia Grande
LFLaura Fratiglioni
Laura Fratiglioni
Introduction: Recent reports from high‐income countries have suggested a declining incidence of dementia.Methods: Trends in dementia incidence over 25 years among people ≥75 years of age were examined using two population‐based cohort studies: the Kungsholmen Project (KP, n = 1473, 1987‐1998) and the Swedish National study on Aging and Care in Kungsholmen (SNAC‐K, n = 1746, 2001‐2013).Results: We identified 440 (29.9%) and 388 (22.2%) incident dementia cases in the KP and SNAC‐K cohorts, respectively. The incidence of dementia declined by 30% (hazard ratio [HR] = 0.70; 95% confidence interval [CI] 0.61‐0.80) during the second decade. Adjustment of education, psychosocial working conditions, lifestyle, and vascular diseases did not substantially change the results (HR = 0.77, 95% CI 0.65‐0.90). This decline was observed particularly in women and people with elementary education.Discussion: Our study provides direct evidence of a declining trend in dementia incidence. Improved cognitive reserve and cardiovascular health could partially explain the decline.

7 February 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
MDMozhu Ding
Mozhu Ding
NVNgoc Nguyen Viet
Ngoc Nguyen Viet
BGBruna Gigante
Bruna Gigante
VLViktor Lind
Viktor Lind
NHNiklas Hammar
Niklas Hammar
KMKarin Modig
Karin Modig
Background: The role of uric acid is gaining increasing importance in the evaluation of cardiovascular disease, but its relationship with atrial fibrillation (AF) is unclear. This study aims to investigate the association between uric acid levels and risk of new‐onset AF. Methods and Results: A total of 339 604 individuals 30 to 60 years of age and free from cardiovascular disease at baseline (1985–1996) in the Swedish AMORIS (Apolipoprotein‐Mortality Risk) cohort were followed until December 31, 2019 for incident AF. Cox regression models were used to examine the association between uric acid and AF, adjusting for potential confounders and stratifying by incident cardiovascular disease. Over a mean follow‐up of 25.9 years, 46 516 incident AF cases occurred. Compared with the lowest uric acid quartile, each of the upper 3 quartiles were associated with an increased risk of AF in a dose–response manner. Adjusted hazard ratios were 1.09 (95% CI, 1.06–1.12) for second quartile, 1.19 (95% CI, 1.16–1.23) for third quartile, and 1.45 (95% CI, 1.41–1.49) for fourth quartile. The association was similar among individuals with and without incident hypertension, diabetes, heart failure, or coronary heart disease. The dose–response pattern was further supported in a subsample of individuals with repeated measurements of uric acid. Conclusions: Elevated uric acid was associated with an increased risk of AF, not only among people with cardiovascular disease and cardiovascular risk factors but also among those without. Future investigations are needed to examine whether lowering uric acid is relevant for AF prevention.

1 September 2021 in Hypertension
Verified
Journal Article
Open access
PDF file
XXXin Xia
Xin Xia
RWRui Wang
Rui Wang
DVDavide Liborio Vetrano
Davide Liborio Vetrano
GGGiulia Grande
Giulia Grande
ELErika J. Laukka
Erika J. Laukka
CQChengxuan Qiu
Chengxuan Qiu
The role of orthostatic hypotension (OH) in the continuum of cognitive aging remains to be clarified. We sought to investigate the associations of OH with dementia, cognitive impairment, no dementia (CIND), and CIND progression to dementia in older adults while considering orthostatic symptoms. This population-based cohort study included 2532 baseline (2001–2004) dementia-free participants (age ≥60 years; 62.6% women) in the SNAC-K (Swedish National Study on Aging and Care in Kungsholmen) who were regularly examined over 12 years. We further divided the participants into a baseline CIND-free cohort and a CIND cohort. OH was defined as a decrease by ≥20/10 mm Hg in systolic/diastolic blood pressure upon standing and further divided into asymptomatic and symptomatic OH. Dementia was diagnosed following the international criteria. CIND was defined as scoring ≥1.5 SDs below age group-specific means in ≥1 cognitive domain. Data were analyzed with flexible parametric survival models, controlling for confounding factors. Of the 2532 participants, 615 were defined with OH at baseline, and 322 were diagnosed with dementia during the entire follow-up period. OH was associated with an adjusted hazard ratio of 1.40 for dementia (95% CI, 1.10–1.76), 1.15 (0.94–1.40) for CIND, and 1.54 (1.05–2.25) for CIND progression to dementia. The associations of dementia and CIND progression to dementia with asymptomatic OH were similar to overall OH, whereas symptomatic OH was only associated with CIND progression to dementia. Our study suggests that OH, even asymptomatic OH, is associated with increased risk of dementia and accelerated progression from CIND to dementia in older adults.

1 December 2017 in International Journal of Cardiology
Verified
Journal Article
Closed access
MDMozhu Ding
Mozhu Ding
LFLaura Fratiglioni
Laura Fratiglioni
KJKristina Johnell
Kristina Johnell
JFJohan Fastbom
Johan Fastbom
MLMaria Ljungdahl
Maria Ljungdahl
CQChengxuan Qiu
Chengxuan Qiu